{Building towards improved therapies for each breast cancer patient}


navline2

Therapy for each breast cancer patient
needs to be optimized to avoid the delays,
side-effects, and costs of ineffective treatments.

PET/X combines PET (positron emmision
tomography and X-ray mammography to
quickly and reliably determine which targeted
breast cancer therapies will be effective for each patient.

PET/X is also valuable for testing efficacy in
newly developed treatments in clinical trials.


Our instrument is currently under development for.
research use only. It is not FDA approved.

Our Team:    Lawrence MacDonald
Paul Kinahan
William Hunter

 

navline
Affilates of UW C4C  and  WBBA